Obesity can mess up the brain for good; here's how
Those extra pounds, which may seem harmless, could be really messing with your mind. And it's not what you think. Obesity may do more than harm physical health, it could also contribute to anxiety and cognitive dysfunction.
Tired of too many ads? go ad free now
A new study found that obesity contributes to anxiety and cognitive impairment
A
, led by Desiree Wanders, PhD, of Georgia State University, looked at how diet-induced obesity affects behavior and brain function.
Obesity and anxiety
and anxiety rates are rising, especially among younger Americans, and the new research suggests that the two conditions are connected. The research conducted in mice linked diet-induced obesity with anxiety-like symptoms, alterations in brain signaling, and differences in gut microbes that may contribute to impaired brain functioning.
'Several studies have pointed to a link between obesity and anxiety, though it is still unclear whether obesity directly causes anxiety or if the association is influenced by societal pressures. Our findings suggest that obesity can lead to anxiety-like behavior, possibly due to changes in both brain function and gut health,' Desiree Wanders, PhD, associate professor and chair of nutrition at Georgia State University, said in a statement.
What obesity does to the brain
Though it is known that
can lead to conditions like type 2 diabetes and heart disease, the potential impacts on brain health are less clear. To understand the connections between obesity, cognitive function, and anxiety, the researchers designed a series of experiments in 32 male mice. During the 6 to 21 weeks of age (equivalent to adolescence into early adulthood in humans), half of the mice were fed a low-fat diet and half were fed a high-fat diet.
Tired of too many ads? go ad free now
The researchers found that the mice fed a high-fat diet weighed significantly more and had significantly more body fat than those fed a low-fat diet, towards the end of the study.
They also found that the obese mice displayed more anxiety-like behaviors, such as freezing (a defensive behavior mice exhibit in response to a perceived threat), compared with lean mice. Interestingly, these mice also showed different signaling patterns in the hypothalamus, a region of the brain involved in regulating metabolism, which could contribute to cognitive impairments.
The researchers also observed distinct differences in the makeup of gut bacteria in obese mice compared with lean mice.
'These findings could have important implications for both public health and personal decisions. The study highlights the potential impact of obesity on mental health, particularly in terms of anxiety. By understanding the connections between diet, brain health and gut microbiota, this research may help guide public health initiatives that focus on obesity prevention and early intervention, particularly in children and adolescents,' Wanders said.
Diabetes & Obesity
'While our findings suggest that diet plays a significant role in both physical and mental health, it is important to remember that diet is just one piece of the puzzle. Environmental factors, genetics, lifestyle choices and socioeconomic status also contribute to the risk of obesity and its associated health outcomes. Therefore, while these results are important, they should be considered in the context of a broader, multifactorial approach to understanding and addressing obesity-related cognitive impairments and mental health issues,' Wanders added.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
8 hours ago
- Time of India
US grocery prices: Sticker shock: How U.S. grocery bills stack up against Mexico, Canada, and China in surprising price reveal
United States ADVERTISEMENT Canada ADVERTISEMENT Mexico ADVERTISEMENT China FAQs While housing expenses rose during and after the pandemic, food prices went up even higher, as per a report. According to the USDA, from 2020 through 2024, food prices in the United States increased 23.6%, surpassing the 23.0% increase in housing expenses, as per food inflation has slowed considerably since then. Having peaked at 11.4% in 2022, it fell to 5.0% in 2023 and further to merely 1.2% in 2024, reported GoBankingRates at the grocery store, Americans are spending more than many of their international neighbours, as per the report. Here's a comparison of US grocery affordability with Canada, Mexico, and China based on statistics from Numbeo, the USDA, and experts GoBankingRates spoke READ: Mark Cuban predicts painful red rural recession — here are 4 states he says should brace for economic fallout Grocery Cost Index: 71.75, as per of Average Consumer Expenditure: 6.8%, as per USDA data processed by Our World in to GobankingRates report, in absolute terms, groceries are more expensive in the United States than in Canada, Mexico, or China. But as a percentage of income, Americans are spending less on food than citizens of those nations , which is only 6.8% of the American's budget, as per the finance expert, Aaron Razon explained that, 'The U.S. imports groceries from other countries like Mexico and Canada, for year-round availability,' quoted GoBankingRates. Razon also mentioned that 'Add in the high cost of local labor and the impact of trade policies and tariffs on grocery prices, it's really no surprise that groceries would cost more in the U.S. than it does in these other countries,' as quoted in the Cost Index: 65.35Percentage of Average Consumer Expenditure: 9.7%According to a Numbeo report, groceries in Canada cost 5.8% less when they are priced in the same currency. However, the median Canadian also earns lesser than the median American, so an average Canadian household spends 9.7% of its budget on groceries, reported GobankingRates Cost Index: 38.22Share of Average Consumer Spending: 25.7%In Mexico, groceries are 42.3% cheaper in absolute terms, but even incomes are lower as well, as per Numbeo. While, Mexican households also have limited access to imported foods compared to Americans, and other than big cities, most Mexican families mainly eat locally grown food, reported Shalini Dharna said, 'In general, consumers in Mexico tend to have less disposable income than in the U.S. and Canada, so in relative terms groceries are more affordable in the U.S. than in Mexico,' quoted the GoBankingRates Cost Index: 34.18Percentage of Average Consumer Expenditure: 21.2%Groceries are even cheaper in China, which is 53.1% cheaper than in the United States, as per the report. However, food takes up a high portion of the average Chinese household's budget, especially for low-wage rural workers providing cheap labour, reported said, 'China's large-scale agricultural production and low labor costs put them at an advantage when it comes to affordability,' as quoted in the After peaking at 11.4% in 2022, it dropped to 5.0% in 2023 and then to just 1.2% in 2024, as per GoBankingRates in Canada cost about 5.8% less than in the US, but Canadians typically earn less, so they end up spending 9.7% of their income on food, as per GobankingRates report.
Indian Express
11 hours ago
- Indian Express
From no hope to a potential cure for a deadly blood cancer
A group of 97 patients had longstanding multiple myeloma, a common blood cancer that doctors consider incurable, and faced a certain, and extremely painful, death within about a year. They had gone through a series of treatments, each of which controlled their disease for a while. But then it came back, as it always does. They reached the stage where they had no more options and were facing hospice. They all got immunotherapy, in a study that was a last-ditch effort. A third responded so well that they got what seems to be an astonishing reprieve. The immunotherapy developed by Legend Biotech, a company founded in China, seems to have made their cancer disappear. And after five years, it still has not returned in those patients — a result never before seen in this disease. These results, in patients whose situation had seemed hopeless, has led some battle-worn American oncologists to dare to say the words 'potential cure.' 'In my 30 years in oncology, we haven't talked about curing myeloma,' said Dr. Norman Sharpless, a former director of the National Cancer Institute who is now a professor of cancer policy and innovation at the University of North Carolina School of Medicine. 'This is the first time we are really talking seriously about cure in one of the worst malignancies imaginable.' The new study, reported Tuesday at the annual conference of the American Society of Clinical Oncology and published in The Journal of Clinical Oncology, was funded by Johnson & Johnson, which bought Legend Biotech. The 36,000 Americans who develop multiple myeloma each year face an illness that eats away at bones, so it looks as though holes have been punched out in them, said Dr. Carl June, of the University of Pennsylvania. Bones collapse. Dr. June has seen patients who lost six inches in height. 'It's a horrible, horrible death,' Dr. June said. 'Right now advanced myeloma is a death sentence.' (Dr. June has immunotherapy patents that are owned by his university.) There have been treatment advances that increased median survival from two years to 10 over the past two decades. But no cures. Dr. Peter Voorhees of the Atrium Health Levine Cancer Institute in North Carolina and the Wake Forest University School of Medicine, who is lead researcher for the newly published study, said patients usually go through treatment after treatment until, ultimately, the cancer prevails, developing resistance to every class of drug. They end up with nothing left to try. The Legend immunotherapy is a type known as CAR-T. It is delivered as an infusion of the patient's own white blood cells that have been removed and engineered to attack the cancer. The treatment has revolutionized prospects for patients with other types of blood cancer, like leukemia. Making CAR-T cells, though, is an art, with so many possible variables that it can be hard to hit on one that works. And it can have severe side effects including a high fever, trouble breathing and infections. Patients can be hospitalized for weeks after receiving it. But Legend managed to develop one that works in multiple myeloma, defying skeptics. The Chinese company gained attention for its CAR-T eight years ago when it made extravagant claims, which were met by snickers from American researchers. Johnson & Johnson, though, was looking for a CAR-T to call its own. So, said Mark Wildgust, an executive in the oncology section of the American drug giant, the company sent scientists and physicians to China to see if the claims were true. 'We went site by site to look at the results,' he said. The company was convinced. It bought Legend and began testing the treatment in patients whose myeloma had overcome at least one standard treatment. Compared with patients who had standard treatment, those who had the immunotherapy lived longer without their disease progressing. The immunotherapy received regulatory approval in that limited setting and is sold under the brand name Carvykti. The study did not determine whether this difficult treatment saved lives. The new study took on a different challenge — helping patients at the end of the line after years of treatments. Their immune systems were worn down. They were, as oncologists said, 'heavily pretreated.' So even though CAR-T is designed to spur their immune systems to fight their cancer, it was not clear their immune systems were up to it. Oncologists say that even though most patients did not clear their cancer, having a third who did was remarkable. To see what the expected life span would be for these patients without the immunotherapy, Johnson & Johnson looked at data from patients in a registry who were like the ones in its study — they had failed every treatment. They lived about a year. For Anne Stovell of New York, one of the study patients whose cancer disappeared, the result is almost too good to be true. She says she went through nine drugs to control her cancer after it was diagnosed in 2010, some of which had horrendous side effects. Each eventually failed. Taking the Legend CAR-T was difficult — she said she had spent nearly three weeks in the hospital. But since that treatment six years ago, she has no sign of cancer. She said it was still difficult for her to believe her myeloma is gone. A new ache — or an old one — can bring on the fear. 'There's that little seed of doubt,' she said. But in test after test, the cancer has not reappeared. 'It's a relief for me every year to get a bone marrow biopsy,' she said. Myeloma experts applauded the results. Like treatments for many other cancers, treatments for multiple myeloma come with a high price. The drugs are 'hideously expensive,' Dr. June said, costing more than $100,000 a year. The total cost over the years can be millions of dollars, Dr. June said, usually paid by insurers, 'and it doesn't even cure you.' CAR-T is expensive too. Carvykti's list price is $555,310. But it is a one-time treatment. And, more important, the hope is that perhaps by giving it earlier in the course of the disease, it could cure patients early on. Johnson & Johnson is now testing that idea. Dr. Kenneth Anderson, a myeloma expert at Dana-Farber Cancer Institute who was not involved with the study, said that if the treatment is used as a first-line treatment, 'cure is now our realistic expectation.' That, at least, is the hope, Dr. Sharpless said. And for those like the patients in the new study who are living at least five years — so far — without disease, the outcome 'really is eye-popping,' Dr. Sharpless said. 'That's getting to a point where you wonder if it will ever come back,' he added. Gina Kolata reports on diseases and treatments, how treatments are discovered and tested, and how they affect people.
Time of India
17 hours ago
- Time of India
All international travelers should get measles vaccinations, CDC says
New York: U.S. health officials have changed their advice to international travelers about measles, saying that Americans should be vaccinated against the virus no matter where they're going. U.S. residents are recommended to get measles-mumps-rubella shots , anyway. But the Centers for Disease Control and Prevention previously emphasized the importance of vaccination for travelers going to countries with outbreaks. Last week, the CDC updated its guidance to call for vaccinations for travelers going to all other countries. Ashley Darcy-Mahoney, a researcher at George Washington University's nursing school, called the update significant. An Colorado outbreak last month stemmed from an international flight that landed in Denver, she noted. The CDC travel notice change reflects a recognition that people are not just being exposed to measles in countries where it's spreading, but also in airplanes and during travel, she added. "We're seeing a shift from localized outbreaks to transmission in transit," and the CDC seems to be responding to that, Darcy-Mahoney said. The travel notice advises two doses for all Americans ages 1 and older. An early dose is advised for traveling infants ages 6 months to 11 months. The U.S. has seen more than 1,000 measles cases so far this year.
